Bright Minds Biosciences (DRUG) Change in Cash (2019 - 2026)

Bright Minds Biosciences (DRUG) has 7 years of Change in Cash data on file, last reported at $159.9 million in Q1 2026.

• Quarterly Change in Cash rose 10526.73% year-over-year to $159.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $186.0 million (up 439.97% YoY) and the FY2025 annual result came in at $55.9 million, up 7429.91% from the prior year.
• Change in Cash advanced to $159.9 million in Q1 2026, from $5.4 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $159.9 million in Q1 2026 to a low of -$15.1 million in Q3 2022.
• A 5-year average of $12.1 million and a median of $159537.1 in 2024 frame the typical range for Change in Cash.
• Annual changes were most pronounced in 2024 — Change in Cash jumped 87934.57% — and 2025, when it plunged 1692.74%.
• Tracing DRUG's Change in Cash over 5 years: stood at -$301578.2 in 2022, then soared by 113.63% to $41101.7 in 2023, then jumped by 87934.57% to $36.2 million in 2024, then sank by 84.99% to $5.4 million in 2025, then jumped by 2842.94% to $159.9 million in 2026.
• The last three Change in Cash figures came in at $159.9 million (Q1 2026), $5.4 million (Q4 2025), and $23.3 million (Q3 2025), per Business Quant data.